Detailed definition
Recurrent urinary tract infection (rUTI) is defined as ≥2 culture-proven UTIs in 6 months or ≥3 in 12 months. In postmenopausal women, rUTI is strongly linked to GSM: estrogen deprivation thins the urethral and vaginal epithelium, raises vaginal pH, depletes lactobacilli, and shifts vaginal flora toward gram-negative uropathogens (especially E. coli) that ascend the urethra. Multiple randomized trials and meta-analyses (Cochrane review 2008 and subsequent updates) show that vaginal estrogen — cream, tablet, or ring — reduces rUTI frequency by roughly 50% in postmenopausal women, making it one of the most evidence-supported preventive interventions in this population. Other measures include adequate hydration, post-coital voiding, methenamine hippurate as a non-antibiotic suppressive option, cranberry products (modest evidence), and antibiotic prophylaxis when other measures fail.
Why it matters in menopause
Many postmenopausal women on rotating courses of antibiotics for "another UTI" have never been offered vaginal estrogen. The evidence is strong, the side effect profile is mild, and the recurrence reduction is meaningful. ClearedRx prescribes vaginal estrogen for postmenopausal rUTI alongside or independently of systemic HRT.
Related terms
Sources
External references: Wikipedia.